Welcome to LookChem.com Sign In|Join Free

CAS

  • or
BOC-PHE-LEU-OH is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

33014-68-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 33014-68-5 Structure
  • Basic information

    1. Product Name: BOC-PHE-LEU-OH
    2. Synonyms: BOC-PHE-LEU-OH;BOC-L-PHENYLALANYL LEUCINE;(S)-2-((S)-2-(tert-butoxycarbonylamino)-3-phenylpropanamido)-4-methylpentanoic acid;REF DUPL: Boc-Phe-Leu-OH;alpha-tert-Butoxycarbonyl-L-phenylalanyl-L-leucine;Boc-Phe-Leu-OH≥ 97.5% (HPLC);(Tert-Butoxy)Carbonyl Phe-Leu-OH
    3. CAS NO:33014-68-5
    4. Molecular Formula: C20H30N2O5
    5. Molecular Weight: 378.46
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 33014-68-5.mol
  • Chemical Properties

    1. Melting Point: 136-138 °C
    2. Boiling Point: 603.3oC at 760 mmHg
    3. Flash Point: 318.7oC
    4. Appearance: /
    5. Density: 1.131g/cm3
    6. Vapor Pressure: 2.1E-15mmHg at 25°C
    7. Refractive Index: 1.52
    8. Storage Temp.: Store at 0°C
    9. Solubility: N/A
    10. PKA: 3.49±0.10(Predicted)
    11. CAS DataBase Reference: BOC-PHE-LEU-OH(CAS DataBase Reference)
    12. NIST Chemistry Reference: BOC-PHE-LEU-OH(33014-68-5)
    13. EPA Substance Registry System: BOC-PHE-LEU-OH(33014-68-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 33014-68-5(Hazardous Substances Data)

33014-68-5 Usage

Chemical Properties

White to off-white powder

Check Digit Verification of cas no

The CAS Registry Mumber 33014-68-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,0,1 and 4 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 33014-68:
(7*3)+(6*3)+(5*0)+(4*1)+(3*4)+(2*6)+(1*8)=75
75 % 10 = 5
So 33014-68-5 is a valid CAS Registry Number.
InChI:InChI=1/C20H30N2O5/c1-13(2)11-16(18(24)25)21-17(23)15(12-14-9-7-6-8-10-14)22-19(26)27-20(3,4)5/h6-10,13,15-16H,11-12H2,1-5H3,(H,21,23)(H,22,26)(H,24,25)

33014-68-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name BOC-PHE-LEU-OH

1.2 Other means of identification

Product number -
Other names REF DUPL: Boc-Phe-Leu-OH

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:33014-68-5 SDS

33014-68-5Relevant articles and documents

New cysteine protease inhibitors: Electrophilic (Het)arenes and unexpected prodrug identification for the trypanosoma protease rhodesain

Barthels, Fabian,Distler, Ute,Engels, Bernd,Hellmich, Ute A.,Johe, Patrick,Jung, Sascha,Kühlborn, Jonas,Klein, Philipp,Opatz, Till,Schirmeister, Tanja,Tenzer, Stefan,Wagner, Annika,Waigel, Waldemar

, (2020/03/27)

Electrophilic (het)arenes can undergo reactions with nucleophiles yielding π- or Meisenheimer (σ-) complexes or the products of the SNAr addition/elimination reactions. Such building blocks have only rarely been employed for the design of enzyme inhibitors. Herein, we demonstrate the combination of a peptidic recognition sequence with such electrophilic (het)arenes to generate highly active inhibitors of disease-relevant proteases. We further elucidate an unexpected mode of action for the trypanosomal protease rhodesain using NMR spectroscopy and mass spectrometry, enzyme kinetics and various types of simulations. After hydrolysis of an ester function in the recognition sequence of a weakly active prodrug inhibitor, the liberated carboxylic acid represents a highly potent inhibitor of rhodesain (Ki = 4.0 nM). The simulations indicate that, after the cleavage of the ester, the carboxylic acid leaves the active site and re-binds to the enzyme in an orientation that allows the formation of a very stable π-complex between the catalytic dyad (Cys-25/His-162) of rhodesain and the electrophilic aromatic moiety. The reversible inhibition mode results because the SNAr reaction, which is found in an alkaline solvent containing a low molecular weight thiol, is hindered within the enzyme due to the presence of the positively charged imidazolium ring of His-162. Comparisons between measured and calculated NMR shifts support this interpretation.

Naphthoquinones as covalent reversible inhibitors of cysteine proteases—studies on inhibition mechanism and kinetics

Barthels, Fabian,Distler, Ute,Engel, Volker,Engels, Bernd,Hellmich, Ute A.,Johe, Patrick,Klein, Philipp,Le, Thien Anh,Opatz, Till,Schirmeister, Tanja,Schmid, Paul,Tenzer, Stefan,Wagner, Annika

, (2020/05/16)

The facile synthesis and detailed investigation of a class of highly potent protease inhibitors based on 1,4‐naphthoquinones with a dipeptidic recognition motif (HN‐L‐Phe‐L‐Leu‐OR) in the 2‐position and an electron‐withdrawing group (EWG) in the 3‐positio

Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors

Mou, Jiajia,Fang, Hao,Liu, Yingzi,Shang, Luqing,Wang, Qiang,Zhang, Lei,Xu, Wenfang

scheme or table, p. 887 - 895 (2010/05/02)

A series of bi- or tri-peptide analogues with the scaffold l-arginine were designed, synthesized and evaluated for their inhibitory activities against amino-peptidase N (APN) and metalloproteinase-2 (MMP-2). The primary activity assay showed that all the compounds exhibited higher inhibitory activities against APN than MMP-2. Within this series, compounds C6 and C7 (IC50 = 4.2 and 4.3 μM) showed comparable APN inhibitory activities with the positive control bestatin (IC50 = 3.8 μM).

Fabrication of luminescent cds nanoparticles on short-peptide-based hydrogel nanofibers: Tuning of Optoelectronic Properties

Palui, Goutam,Nanda, Jayanta,Ray, Sudipta,Banerjee, Arindam

supporting information; experimental part, p. 6902 - 6909 (2010/03/02)

The pH-induced self-assembly of three synthetic tripeptides in water medium is used to immobilize luminescent CdS nanoparticles. These peptides form a nanofibrillar network structure upon gelation in aqueous medium at basic pH values (pH 11.013.0), and th

Design and synthesis of a novel class of furan-based molecules as potential 20S proteasome inhibitors

Fu, Yiqiu,Xu, Bo,Zou, Xiaomin,Ma, Chao,Yang, Xiaoming,Mou, Ke,Fu, Gang,Lue, Yang,Xu, Ping

, p. 1102 - 1106 (2007/10/03)

A novel class of furan-based compounds as potential 20S proteasome inhibitors have been designed and synthesized, among which nine compounds are peptide derivatives and six molecules are statine peptidomimetics. The C-terminal furanyl moiety was introduced to target molecules as furan-based amino acids. All the compounds were obtained steadily with moderate to high yield. Compound 12 was a selective moderate potent proteasome peptidomimetic inhibitor. It inhibited HepG2 and HL-60 proliferation effectively.

A novel and efficient method for cleavage of phenacylesters by magnesium reduction with acetic acid

Kokinaki, Stella,Leondiadis, Leondios,Ferderigos, Nikolas

, p. 1723 - 1724 (2007/10/03)

(Equation Presented) In the present study, we use magnesium turnings as a new deprotection reagent for the phenacyl group during orthogonal organic synthesis in the presence of other esters and sensitive protecting groups. By applying the new magnesium turnings/acetic acid deprotection method, phenacyl group can be more easily combined with other protecting groups that are not compatible with the zinc/acetic acid method.

Synthesis of small cyclic peptides constrained with 3-(3-aminomethylphenyl) propionic acid linkers using free radical-mediated macrocyclization

Balraju,Reddy, D. Srinivasa,Periasamy, Mariappan,Iqbal, Javed

, p. 5207 - 5210 (2007/10/03)

In this letter, we report that small peptides (di- and tri-) having a 3-bromobenzyl group at the C-termini and an acryloyl group at the N-termini undergo an efficient Bu3SnH-AIBN mediated intramolecular free radical cyclization to afford cyclic

β-Turn mimic in tripeptide with Phe(1)-Aib(2) as corner residues and β-strand structure in an isomeric tripeptide: An X-ray diffraction study

Dutt, Anita,Froehlich, Roland,Pramanik, Animesh

, p. 661 - 665 (2007/10/03)

A single crystal X-ray diffraction study of the tripeptide Boc-Phe-Aib-Leu-OMe (Aib = α-aminoisobutyric acid) reveals that it forms structurally one of the best type II β-turns so far reported in tripeptides, stabilized by 10 atom intramolecular hydrogen

Synthesis, characterization and biological evaluation of cyclic peptides: Viscumamide, yunnanin A and evolidine

Poojary, Boja,Belagali

, p. 1313 - 1320 (2008/02/08)

Three biologically active cyclic peptides, viscumamide, yunnanin A and evolidine were synthesized and the structures were established on the basis of analytical, IR, NMR and mass spectral data. These newly synthesized cyclic peptides were evaluated for an

Synthesis of a novel cis-proline-derived cyclic type VI β-turn mimic via ring-closing metathesis

Boruah, Anima,Rao, I. Nageshwar,Nandy, Jyoti Prokash,Kumar, S. Kiran,Kunwar,Iqbal, Javed

, p. 5006 - 5008 (2007/10/03)

A cis-proline derived cyclic mimic of a type VI β-turn is synthesized via a ring-closing metathesis reaction. The solution NMR conformational study indicates that the major conformer of the cyclic peptide adopts a type VIa β-turn in CDCl3 and a type VIb β-turn in DMSO-d6.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 33014-68-5